1 – 34 of 34
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
High need for intensive care in paediatric acute myeloid leukaemia : A population-based study
(
- Contribution to journal › Article
-
Mark
A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
(
- Contribution to journal › Article
- 2021
-
Mark
Hospitalizations in long-term survivors of childhood AML treated with allogeneic HCT—An Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study
(
- Contribution to journal › Letter
-
Mark
Extracorporeal Membrane Oxygenation Support in Children with Hematological Malignancies in Sweden
(
- Contribution to journal › Article
-
Mark
Mutational patterns and clonal evolution from diagnosis to relapse in pediatric acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2020
-
Mark
Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia : a Nordic Society of Pediatric Hematology and Oncology study
(
- Contribution to journal › Article
- 2018
-
Mark
Determination of blood cell subtype concentrations from frozen whole blood samples using TruCount beads
(
- Contribution to journal › Article
- 2017
-
Mark
Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing
(
- Contribution to journal › Article
- 2016
-
Mark
Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia
(
- Contribution to journal › Article
-
Mark
PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Parents' and Adolescents' Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.
(
- Contribution to journal › Article
-
Mark
Trisomy 8 in pediatric acute myeloid leukemia : A NOPHO-AML study
(
- Contribution to journal › Article
-
Mark
Acute myeloid leukemia in adolescents and young adults treated in pediatric and adult departments in the nordic countries.
(
- Contribution to journal › Article
-
Mark
Leukemic blasts are present at low levels in spinal fluid in one-third of childhood acute lymphoblastic leukemia cases
(
- Contribution to journal › Article
- 2015
-
Mark
The applicability of the WHO classification in paediatric AML. A NOPHO-AML study
(
- Contribution to journal › Article
-
Mark
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
(
- Contribution to journal › Article
- 2014
-
Mark
Ploidy and clinical characteristics of childhood acute myeloid leukemia: A NOPHO-AML study
(
- Contribution to journal › Article
-
Mark
Prognostic Implications of Mutations in NOTCH1 and FBXW7 in Childhood T-ALL Treated According to the NOPHO ALL-1992 and ALL-2000 Protocols
(
- Contribution to journal › Article
-
Mark
Emergence of New ALK Mutations at Relapse of Neuroblastoma.
(
- Contribution to journal › Article
- 2013
-
Mark
Promoter DNA Methylation Pattern Identifies Prognostic Subgroups in Childhood T-Cell Acute Lymphoblastic Leukemia
(
- Contribution to journal › Article
-
Mark
A glycosylation-dependent CD45RB epitope defines previously unacknowledged CD27-IgMhigh B cell subpopulations enriched in young children and after hematopoietic stem cell transplantation
(
- Contribution to journal › Article
-
Mark
Outcome of poor response paediatric AML using early SCT
(
- Contribution to journal › Article
- 2012
-
Mark
Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
(
- Contribution to journal › Article
-
Mark
High ERG gene expression is an unfavorable prognostic marker in pediatric acute myeloid leukemia Response
(
- Contribution to journal › Letter
- 2011
-
Mark
Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate.
(
- Contribution to journal › Article
-
Mark
Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.
(
- Contribution to journal › Article
-
Mark
Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
(
- Contribution to journal › Article
- 2009
-
Mark
Individualized 6-Mercaptopurine Increments During Consolidation Treatment Of Lower Risk Childhood All
(
- Contribution to journal › Published meeting abstract
-
Mark
In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article
- 2008
-
Mark
Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Age and Prognosis in Pediatric AML
(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Improved outcome after relapse in children with acute myeloid leukaemia
(
- Contribution to journal › Article
- 2006
-
Mark
Pathways through relapses and deaths of children with acute lymphoblastic leukemia: Role of allogeneic stem-cell transplantation in Nordic data
(
- Contribution to journal › Article